International Program Committee

Malini Chatterjee, PhD,

Managing Director @ Blueprint Lifescience Group, East Coast operations. She joined Blueprint after a 10-year period of investing as analyst and eventually portfolio manager for biotech, specialty pharma and pharma stocks at institutional funds such as CR Intrinsic Investors/SAC Capital, Alexandra Investments. 

Yvette Cleland

CEO of CPL Life Sciences, London, UK, a global staffing firm specializing in Biopharma. Yvette has been recognized since 2018 by Staffing Industry Analysts (SIA) as one of the top 50 most powerful women, in staffing, globally.

Vanessa El Harrar, MD, MPH,

Vice President, Vaccines Business Strategy Lead, @ PPD BIOTECH [Thermo Fisher Group]. Boca Raton, FL, USA. Previously, Dr El Harrar was Director of Therapeutic Research, Office of the Director, NIH: National Institutes of Health, Bethesda, MD, USA

Jessica FOLEY, MS, RAC

Principal Consultant and Founder of Gaia Regulatory Sciences, LLC, CIC Cambridge, MA. Senior regulatory professional, providing strategic due diligence, product development and approval strategies through her consultancy, with a focus on investigational therapies for the treatment of rare and common conditions.

Shahin Gharakhanian, MD, DPH
[Principal & Program Chair]

Co-founder in 2017, Boston-Paris Biotechnology Summit® Principal & Chief Medical Officer Shahin Gharakhanian MD Consulting LLC, CIC: Cambridge Innovation Center Cambridge MA, USA

Silvia Helou, MD

Principal & Executive Consultant, HELOU Consulting LLC, New York Metropolitan Area, NY, USA. Dr Helou has extensive drug development experience in major therapeutic areas including anti-infectives, dermatology, oncology/hematology, and immunology/biologics. She previously held various senior positions at Novartis, Schering-Plough and Scynexis in clinical development.

Frederic Jallat, PhD

Professor & Academic Director, ESCP Paris European Business School, Paris, FRANCE. Campuses: Berlin, London, Madrid, Paris, Turin, and Warsaw. Frederic Jallat, PhD (ESSEC) and New York University is a leading Thought Leader in France/EU in the field of Pharmaceutical & Life Sciences educational strategy.

Abderrahim Lachgar, PhD

CEO PARIMMUNE, Lille, FRANCE & Board of Directors, APMONIA, Reims, FRANCE.

Hector Rosado, MBA

Associate Director of Program Management / Chief of Staff Global Medical Neuroscience at Takeda Pharmaceuticals. He is a Global Strategic Leader that supports the Neuroscience Therapeutic Area where he provides expertise, structure, strategic support and a collaborative mindset to ensure successful planning, management and execution of projects in alignment with the organization goals.

Yacine Salhi, PhD

Vice President of Biostatistics, Programming, Modeling & Simulation at Sage Therapeutics. He has handled different managerial roles with a focus on Oncology, Infectious, Respiratory, Immunology and Brain disorders therapeutic areas. He contributed to successful regulatory submissions in EU, US, and some other countries.